1. Bird, S.J., Levine, J.M., 2024. Myasthenia Crisis. In J.M. Schefner, P.E. Parsons, & A.A. Rubinstein (Eds.), UpToDate. Available from: https://www.uptodate.com/contents/myasthenic-crisis?search=myasthenia%20gravis%20crisis&source=search_result&selectedTitle=1%7E83&usage_type=default&display_rank=1#H1075786823.
2. Detect It so You Can Treat It: A Case Series and Proposed Checklist to Detect Neurotoxicity in Checkpoint Therapy;Bolz;eNeurologicalSci.,2021
3. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study;Chen;Lancet Regional Health – Western Pacific,2020
4. Pembrolizumab-induced Myasthenia Gravis: Literature review of ocular manifestations and a refractory case;Dugena;J. Immunother.,2022
5. Neurotoxicities associated with immune checkpoint inhibitor therapy;Duong;J. Neurooncol,2021